Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R, Escuriol J, Velasco V, Mayeur L, Soubeyran I, Delfour C, Aubert S, Polivka M, Karanian M, Meurgey A, Le Guellec S, Weingertner N, Hoeller S, Coindre JM, Larousserie F, Pierron G, Tirode F, Le Loarer F.
Perret R, et al. Among authors: soubeyran i.
Mod Pathol. 2020 Oct;33(10):2087. doi: 10.1038/s41379-020-0570-8.
Mod Pathol. 2020.
PMID: 32415264
Free article.